🔴 GT Biopharma is trading 6.31% down today after a 1-for-25 reverse stock split became effective

GT Biopharma is trading at $5.64 (-6.31%) on September 8, 2026, after its 1-for-25 reverse stock split became effective.

• Nasdaq confirmed the split-adjusted trading date and CUSIP change.
• The transaction reduced outstanding shares from approximately 45.1 million to 1.8 million and was intended to support continued Nasdaq trading.
• The move is company-specific, while broader markets are also modestly lower.